| |
| |
|
| Insider
Information: |
Rogers Michael W |
| Relationship: |
|
| City: |
Lexington |
| State: |
MA |
| |
|
| Insider
Summary: |
|
|
|
|
Companies Owned : |
4 |
|
| Direct
Shares |
255,909 |
|
|
Indirect Shares
|
0 |
|
|
| Direct
Value |
$194,166 |
|
|
|
Indirect Value
|
$0 |
|
|
| Total
Shares |
255,909 |
|
|
| Total
Value |
$194,166 |
|
|
|
|
|
|
|
|
Historical
Performance :
Based on 6 Month Return Percentages |
Buys
|
Sells
|
|
Total
Filings :
|
0
|
0
|
|
Stock
price went up :
|
0
|
0
|
| Stock
price went down : |
0
|
0
|
| |
|
|
|
Gain/Loss Ratio : |
0.0
|
0.0
|
| Percentage
Gain/Loss : |
0.0%
|
0.0%
|
| |
|
|
|
|
|
Holdings
:
| Menu |
Company Name |
Ticker |
Relation |
Direct Date |
Direct Shares |
Indirect Date |
Indirect Shares |
Total Value Sold  |
 |
Acorda Therapeutics Inc |
ACOR |
Chief Financial Officer |
2015-12-01 |
40,713 |
2013-10-07 |
0 |
Premium* |
|
|
Keryx Biopharmaceuticals Inc |
KERX |
Director |
2018-12-12 |
0 |
2016-05-26 |
0 |
Premium* |
|
|
EyePoint Pharmaceuticals Inc |
EYPT |
|
2019-06-21 |
119,167 |
2018-06-27 |
0 |
Premium* |
|
|
Akebia Therapeutics, Inc. |
AKBA |
|
2023-06-06 |
96,029 |
2018-12-12 |
0 |
Premium* |
|
|
|
|
|
|
|
|
|
|
|
Records found :
19 |
Free Registration Required For Full Results. Limit: 25
|
 |
Download |
Page 1 of 1
|
| Ticker |
Company Name |
Relation |
Off-Dir-10% |
Trans. Date |
Form |
Action |
Price |
Mkt Value |
D/I |
Shares |
Holdings |
Rank
|
|
|
| 3m +/- |
|
|
Form |
| AKBA |
Akebia Therapeutics, Inc. |
|
– • – |
2023-06-06 |
4 |
A |
$0.00 |
$0 |
D/D |
30,000 |
96,029 |
0 |
- |
|
| AKBA |
Akebia Therapeutics, Inc. |
|
– • – |
2021-06-02 |
4 |
A |
$0.00 |
$0 |
D/D |
13,700 |
52,329 |
0 |
- |
|
| AKBA |
Akebia Therapeutics, Inc. |
|
– • – |
2020-06-05 |
4 |
A |
$0.00 |
$0 |
D/D |
13,700 |
38,629 |
0 |
- |
|
| EYPT |
EyePoint Pharmaceuticals ... |
|
– • – |
2019-06-21 |
4 |
OE |
$0.00 |
$0 |
D/D |
6,667 |
119,167 |
0 |
- |
|
| AKBA |
Akebia Therapeutics, Inc. |
|
– • – |
2019-06-06 |
4 |
A |
$0.00 |
$0 |
D/D |
13,700 |
24,929 |
0 |
- |
|
| KERX |
Keryx Biopharmaceuticals ... |
Director |
– • – |
2018-12-12 |
4 |
D |
$0.00 |
$0 |
D/D |
(30,000) |
0 |
0 |
- |
|
| AKBA |
Akebia Therapeutics, Inc. |
Director |
– • – |
2018-12-12 |
4 |
A |
$0.00 |
$0 |
D/D |
11,229 |
11,229 |
0 |
- |
|
| EYPT |
EyePoint Pharmaceuticals ... |
Director |
– • – |
2018-11-15 |
4 |
OE |
$1.13 |
$113,000 |
D/D |
100,000 |
112,500 |
0 |
- |
|
| KERX |
Keryx Biopharmaceuticals ... |
Director |
– • – |
2018-06-30 |
4 |
A |
$0.00 |
$0 |
D/D |
10,000 |
30,000 |
0 |
- |
|
| EYPT |
EyePoint Pharmaceuticals ... |
Director |
– • – |
2018-06-27 |
4 |
OE |
$0.00 |
$0 |
D/D |
12,500 |
12,500 |
0 |
- |
|
| KERX |
Keryx Biopharmaceuticals ... |
Director |
– • – |
2017-06-09 |
4 |
A |
$0.00 |
$0 |
D/D |
10,000 |
20,000 |
0 |
- |
|
| KERX |
Keryx Biopharmaceuticals ... |
Director |
– • – |
2016-05-26 |
4 |
A |
$0.00 |
$0 |
D/D |
10,000 |
10,000 |
0 |
- |
|
| ACOR |
Acorda Therapeutics Inc |
Chief Financial Officer |
• – – |
2015-12-01 |
4 |
AS |
$38.06 |
$36,689 |
D/D |
(964) |
40,713 |
0 |
- |
|
| ACOR |
Acorda Therapeutics Inc |
Chief Financial Officer |
• – – |
2015-10-07 |
4 |
AS |
$29.52 |
$172,359 |
D/D |
(5,700) |
41,677 |
0 |
- |
|
| ACOR |
Acorda Therapeutics Inc |
Chief Financial Officer |
• – – |
2015-03-04 |
4 |
A |
$0.00 |
$0 |
D/D |
5,872 |
47,377 |
0 |
- |
|
| ACOR |
Acorda Therapeutics Inc |
Chief Financial Officer |
• – – |
2014-12-01 |
4 |
AS |
$35.58 |
$8,183 |
D/D |
(230) |
41,505 |
0 |
- |
|
| ACOR |
Acorda Therapeutics Inc |
Chief Financial Officer |
• – – |
2014-10-07 |
4 |
AS |
$33.10 |
$188,660 |
D/D |
(5,700) |
41,735 |
0 |
- |
|
| ACOR |
Acorda Therapeutics Inc |
Chief Financial Officer |
• – – |
2014-03-05 |
4 |
A |
$0.00 |
$0 |
D/D |
1,835 |
47,435 |
0 |
- |
|
| ACOR |
Acorda Therapeutics Inc |
Chief Financial Officer |
• – – |
2013-10-07 |
4 |
A |
$0.00 |
$0 |
D/D |
45,600 |
45,600 |
0 |
- |
|
19 Records found
|
1
|
Page 1 of 1 |
| |
Free Registration Required For Full Results. Limit: 25
|
|
| |
Transaction Code Key: |
Ownership Code Key |
| |
B |
- Buy |
AB |
- Automatic Buy |
D |
- Direct Ownership |
| |
S |
- Sell |
AS |
- Automatic Sell |
I |
- Indirect Ownership |
|
OE |
- Options Exercised |
A |
- Aquired |
| |
IO |
- Initital Ownership |
D |
- Disposed |
| |
|
|
|
|
|
